Document:

Exhibit
10.8

 

Globis
Acquisition Corp.

805
Third Avenue, 15th floor

New
York, New York 10022

 

December
10, 2020

 

Globis
Capital Management, L.P.

805
Third Avenue, 15th floor

New
York, New York 10022

 

Ladies
and Gentlemen:

 

This
letter will confirm our agreement that, commencing on the effective date (the “Effective Date”) of the registration
statement (the “Registration Statement”) for the initial public offering (the “IPO”) of the securities
of Globis Acquisition Corp. (the “Company”) and continuing until the earlier of (i) the consummation by the Company
of an initial business combination or (ii) the Company’s liquidation (in each case as described in the Registration Statement)
(such earlier date hereinafter referred to as the “Termination Date”), Globis Capital Management, L.P. (the “Affiliate”)
shall make available to the Company certain office space, utilities and secretarial and administrative support as may be required
by the Company from time to time, situated at 805 Third Avenue, 15th floor, New York, New York 10022 (or any successor location).
In exchange therefor, the Company shall pay the Affiliate the sum of $10,000 per month on the Effective Date and continuing monthly
thereafter until the Termination Date; provided, however, that the Company may delay payment of such monthly fee upon a determination
by the audit committee of the board of directors of the Company that the Company lacks sufficient funds held outside of the Trust
Account (as defined below) to pay actual or anticipated expenses in connection with an initial business combination. Any such
unpaid amount shall accrue without interest and either be due and payable no later than the date of the Company’s initial
business combination or at the Affiliate’s option, treated as working capital loans and be convertible into warrants on
terms identical to the private warrants. If the Company does not consummate an initial business combination, any accrued and unpaid
amounts hereunder shall be forgiven. The Affiliate hereby agrees that it does not have any right, title, interest or claim of
any kind in or to any monies that may be set aside in a trust account (the “Trust Account”) to be established upon
the consummation of the IPO (the “Claim”) and hereby waives any Claim it may have in the future as a result of, or
arising out of, any negotiations, contracts or agreements with the Company and will not seek recourse against the Trust Account
for any reason whatsoever.

 

[Signature
Page Follows]

 

    	 	 	 

     

    

 

	 	Very
    truly yours,
	 	 
	 	Globis
    acquisition corp.
	 	 	 
	 	By:	/s/
    Paul Packer
	 	Name:	 Paul
    Packer
	 	Title:	 Chief
    Executive Officer, Chief Financial Officer and Secretary

 

	Acknowledged
    and Agreed:	 
	 	 
	Globis
    Capital Management, L.P.	 
	 	 	 
	By:
    	Globis
    Capital, LLC, its general partner	 
	 	 	 
	By:	/s/
    Paul Packer	 
	Name:	 Paul
    Packer	 
	Title:	 Managing
    Member	 

 

[Signature
Page to Administrative Services Agreement]Exhibit (10)(a)

    

    

    

    

    

    

    Consent of Independent Registered Public Accounting Firm

    

    

    

    

    We consent to the reference to our firm under the caption “Independent Registered Public Accounting Firm” in
      Post-Effective Amendment No. 86 to the 1933 Act Registration Statement (Form N-4 No. 333-36316) and Amendment No. 799 to the 1940 Act Registration
      Statement (Form N-4 No. 811-08517), and to the use therein of our reports dated (a) March 13, 2020, with respect to the consolidated financial statements of The Lincoln National Life Insurance Company and (b) April 15, 2020, with respect to the financial statements of Lincoln Life Variable Annuity Account
      N for the registration of interests in a separate account under individual flexible payment deferred variable annuity contracts.

    

    

    

    

    

    

    

    

    /s/ Ernst & Young LLP

    Philadelphia, Pennsylvania

    December 15, 2020Exhibit (10)(a)

    

    

    

    

    

    

    Consent of Independent Registered Public Accounting Firm

    

    

    

    

    We consent to the reference to our firm under the caption “Independent Registered Public Accounting Firm” in
      Post-Effective Amendment No. 58 to the 1933 Act Registration Statement (Form N-4 No. 033-25990) and Amendment No. 163 to the 1940 Act Registration Statement (Form N-4 No. 811-03214), and to the use therein of our reports dated (a) March 13, 2020, with respect to the consolidated financial statements of The
      Lincoln National Life Insurance Company and (b) April 23, 2020, with respect to the financial statements of Lincoln National Variable Annuity Account C for the registration of interests in a separate account under individual flexible payment deferred variable annuity contracts.

    

    

    

    

    

    

    

    

    /s/ Ernst & Young LLP

    Philadelphia, Pennsylvania

    December 15, 2020Exhibit 4.1

 

SECURITIES PURCHASE AGREEMENT

 

This SECURITIES
PURCHASE AGREEMENT (this “Agreement”), dated as of December 11, 2020, is entered into by and between Odyssey
Group Intl Inc., a Nevada corporation, (the “Company”), and LGH Investments, LLC, a Wyoming limited liability
company (the “Buyer”).

 

A.       The
Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded
by the rules and regulations as promulgated by the United States Securities and Exchange Commission (the “SEC”)
under the Securities Act of 1933, as amended (the “1933 Act”).

 

B.       Upon
the terms and conditions stated in this Agreement, the Buyer desires to purchase and the Company desires to issue and sell, upon
the terms and conditions set forth in this Agreement (i) a Promissory Note of the Company, in the form attached hereto as Exhibit
A (the “Note”), in the original principal amount of $165,000.00 (the “Original Principal Amount”)
(together with any note(s) issued in replacement thereof or as a dividend thereon or otherwise with respect thereto in accordance
with the terms thereof, the “Note”) convertible into shares of common stock of the Company (“Common
Stock”), (ii) a five-year share purchase warrant entitling the Buyer to acquire 470,000 shares of common stock of the
Company, in the form attached hereto as Exhibit B (the “Warrant”) and (ii) two hundred thousand
(200,000) restricted common shares in the Company (“Inducement Shares”) to be delivered to Buyer, via overnight courier
within 7 (seven) calendar days following the Closing Date. On the date at which the Buyer seeks to have the restricted legend removed,
in the event the Company’s share price has declined the Company agrees to issue the Buyer additional shares such that the
aggregate value of the Inducement Shares equal the aggregate value of the Inducement Shares as of the closing date.

 

NOW THEREFORE,
the Company and the Buyer hereby agree as follows:

 

1.                  
Purchase and Sale. On the Closing Date (as defined below), the Company shall issue and sell to the Buyer and the
Buyer agrees to purchase from the Company the (i) Note in the original principal amount of $165,000.00, (ii) Warrant, and (ii)
two hundred thousand Inducement Shares. (collectively the “Securities”).

 

1.1.            
Form of Payment. On the Closing Date, (i) the Buyer shall pay the purchase price of $150,000 (the “Purchase
Price”) at the Closing (as defined below) by wire transfer of immediately available funds to a Company account designated
by the Company, in accordance with the Company’s written wiring instructions, against delivery of the Securities, and (ii)
the Company shall deliver such duly executed Securities on behalf of the Company, to the Buyer, against delivery of such Purchase
Price.

 

1.2.            
Closing Date. The date and time of the issuance and sale of the Securities pursuant to this Agreement (the “Closing
Date”) shall be on or about December 11, 2020, or such other mutually agreed upon time. The closing of the transactions
contemplated by this Agreement (the “Closing”) shall occur on the Closing Date at such location as may be agreed
to by the parties.

 

1.3.            
Share Reservation. The Company shall at all times require its transfer agent to establish a reserve of shares of
its authorized but unissued and unreserved Common Stock in the amount of 2,000,000 shares for purposes of exercise of the Warrant
or conversion of the Note. The Company shall cause the Transfer Agent to agree that it will not reduce the reserve under any circumstances
unless such reduction is pre-approved in writing by the Buyer.

 

 

 

 

 

    	 	1	 

     

    

 

2.                  
Buyer’s Investment Representations; Governing Law; Miscellaneous.

 

 2.1              Buyer’s Investment Representations.

 

(a)              
This Agreement is made in reliance upon the Buyer’s representation to the Company, which by its acceptance
hereof Buyer hereby confirms, that the Securities to be received by it will be acquired for investment for its own account, not
as a nominee or agent, and not with a view to the sale or distribution of any part thereof, and that it has no present intention
of selling, granting participation in, or otherwise distributing the same, but subject nevertheless to any requirement of law that
the disposition of its property shall at all times be within its control.

 

(b)              
The Buyer understands that the Securities are not registered under the 1933 Act, on the basis that the sale provided
for in this Agreement and the issuance of securities hereunder is exempt from registration under the 1933 Act pursuant to Section 4(a)(2)
thereof, and that the Company’s reliance on such exemption is predicated on the Buyer’s representations set forth herein.
The Buyer realizes that the basis for the exemption may not be present if, notwithstanding such representations, the Buyer has
in mind merely acquiring shares of the Securities for a fixed or determinable period in the future, or for a market rise, or for
sale if the market does not rise. The Buyer does not have any such intention.

 

(c)              
The Buyer understands that the Securities may not be sold, transferred, or otherwise disposed of without registration
under the 1933 Act or an exemption therefrom, and that in the absence of an effective registration statement covering the Securities
or an available exemption from registration under the 1933 Act, the Stock must be held indefinitely. In particular, the Buyer is
aware that the Securities may not be sold pursuant to Rule 144 or Rule 701 promulgated under the 1933 Act unless all
of the conditions of the applicable Rules are met. Among the conditions for use of Rule 144 is the availability of current
information to the public about the Company. Such information is not now available, and the Company has no present plans to make
such information available. The Buyer represents that, in the absence of an effective registration statement covering the Securities,
it will sell, transfer, or otherwise dispose of the Securities only in a manner consistent with its representations set forth herein
and then only in accordance with the provisions of Section 5(d) hereof.

 

(d)              
The Buyer agrees that in no event will it make a transfer or disposition of any of the Securities (other than pursuant
to an effective registration statement under the 1933 Act), unless and until (i) the Buyer shall have notified the Company
of the proposed disposition and shall have furnished the Company with a statement of the circumstances surrounding the disposition,
and (ii) if requested by the Company, at the expense of the Buyer or transferee, the Buyer shall have furnished to the Company
either (A) an opinion of counsel, reasonably satisfactory to the Company, to the effect that such transfer may be made without
registration under the 1933 Act or (B) a “no action” letter from the Securities and Exchange Commission to the
effect that the transfer of such securities without registration will not result in a recommendation by the staff of the Securities
and Exchange Commission that action be taken with respect thereto. The Company will not require such a legal opinion or “no
action” letter in any transaction in compliance with Rule 144.

 

(e)              
The Buyer represents and warrants to the Company that it is an “accredited investor” within the meaning
of Securities and Exchange Commission Rule 501 of Regulation D, as presently in effect and, for the purpose of Section 25102(f)
of the California Corporations Code, he or she is excluded from the count of “purchasers” pursuant to Rule 260.102.13
thereunder.

  

2.2              
Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of California
without regard to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions
contemplated by this Agreement shall be brought only in the state courts of California or in the federal courts located in San
Diego, California. The parties to this Agreement hereby irrevocably waive any objection to jurisdiction and venue of any action
instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens.
In the event that any provision of this Agreement or any other agreement delivered in connection herewith is invalid or unenforceable
under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict
therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove invalid
or unenforceable under any law shall not affect the validity or enforceability of any other provision of any agreement. Each party
hereby irrevocably waives personal service of process and consents to process being served in any suit, action or proceeding in
connection with this Agreement or any other Transaction Document by mailing a copy thereof via registered or certified mail or
overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and
agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall
be deemed to limit in any way any right to serve process in any other manner permitted by law. THE COMPANY HEREBY IRREVOCABLY WAIVES
ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION
WITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

 

 

 

 

    	 	2	 

     

    

 

2.3              
Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original
but all of which shall constitute one and the same agreement and shall become effective when counterparts have been signed by each
party and delivered to the other party.

 

2.4              
Headings. The headings of this Agreement are for convenience of reference only and shall not form part of, or affect
the interpretation of, this Agreement.

 

2.5              
Severability. In the event that any provision of this Agreement is invalid or unenforceable under any applicable
statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall
be deemed modified to conform with such statute or rule of law. Any provision hereof which may prove invalid or unenforceable under
any law shall not affect the validity or enforceability of any other provision hereof.

 

2.6              
Entire Agreement; Amendments. This Agreement and the instruments referenced herein contain the entire understanding
of the parties with respect to the matters covered herein and therein and, except as specifically set forth herein or therein,
neither the Company nor the Buyer makes any representation, warranty, covenant or undertaking with respect to such matters. No
provision of this Agreement may be waived or amended other than by an instrument in writing signed by the Buyer.

 

2.7              
Notices. Any notice required or permitted hereunder shall be given in writing (unless otherwise specified herein)
and shall be deemed effectively given on the earliest of:

 

2.7.1         
the date delivered, if delivered by personal delivery as against written receipt therefor or by e-mail to an executive officer,
or by confirmed facsimile,

 

2.7.2         
the fifth Trading Day after deposit, postage prepaid, in the United States Postal Service by registered or certified mail,
or

 

2.7.3         
the third Trading Day after mailing by domestic or international express courier, with delivery costs and fees prepaid,
in each case, addressed to each of the other parties thereunto entitled at the following addresses (or at such other addresses
as such party may designate by ten (10) calendar days’ advance written notice similarly given to each of the other parties
hereto):

 

If to the Company, to:

 

Odyssey Group Intl, Inc.

ATT: Joseph Redmond, CEO

2372 Morse Ave

Irvine, CA 92614

Email: michael@odysseygi.com

 

With Copy to which shall not constitute
notice:

 

Joshua D. Brinen, Esq.

Brinen & Associates, LLC

90 Broad Street, Tenth Floor

New York, New York 10004

 

Telephone (212) 330-8151

Facsimile (212) 227-0201

 

jbrinen@brinenlaw.com

 

If to the Buyer:

 

Lucas Hoppel

Phone: 858-232-5110

Email: Luke@LGHInvestments.com

 

 

 

 

 

    	 	3	 

     

    

 

2.8              
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors
and assigns. Notwithstanding anything to the contrary herein, the rights, interests or obligations of the Company hereunder may
not be assigned, by operation of law or otherwise, in whole or in part, by the Company without the prior written consent of the
Buyer, which consent may be withheld at the sole discretion of the Buyer; provided, however, that in the case of a merger,
sale of substantially all of the Company’s assets or other corporate reorganization, the Buyer shall not unreasonably withhold,
condition or delay such consent. This Agreement or any of the severable rights and obligations inuring to the benefit of or to
be performed by Buyer hereunder may be assigned by Buyer to a third party, including its financing sources, in whole or in part,
without the need to obtain the Company’s consent thereto.

 

2.9              
Third Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective
permitted successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other person.

 

2.10          
Survival. The representations and warranties of the Company and the agreements and covenants set forth in this Agreement
shall survive the Closing hereunder notwithstanding any due diligence investigation conducted by or on behalf of the Buyer. The
Company agrees to indemnify and hold harmless the Buyer and all its officers, directors, employees, attorneys, and agents for loss
or damage arising as a result of or related to any breach or alleged breach by the Company of any of its representations, warranties
and covenants set forth in this Agreement or any of its covenants and obligations under this Agreement, including advancement of
expenses as they are incurred.

 

2.11          
No Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties
to express their mutual intent, and no rules of strict construction will be applied against any party.

 

2.12          
Remedies. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to
the Buyer by vitiating the intent and purpose of the transaction contemplated hereby. Accordingly, the Company acknowledges that
the remedy at law for a breach of its obligations under this Agreement will be inadequate and agrees, in the event of a breach
or threatened breach by the Company of the provisions of this Agreement, that the Buyer shall be entitled, in addition to all other
available remedies at law or in equity, and in addition to the penalties assessable herein, to an injunction or injunctions restraining,
preventing or curing any breach of this Agreement and to enforce specifically the terms and provisions hereof, without the necessity
of showing economic loss and without any bond or other security being required.

 

2.13          
Buyer’s Rights and Remedies Cumulative. All rights, remedies, and powers conferred in this Agreement and the
Transaction Documents on the Buyer are cumulative and not exclusive of any other rights or remedies, and shall be in addition to
every other right, power, and remedy that the Buyer may have, whether specifically granted in this Agreement or any other Transaction
Document, or existing at law, in equity, or by statute; and any and all such rights and remedies may be exercised from time to
time and as often and in such order as the Buyer may deem expedient.

 

2.14          
Ownership Limitation. If at any time after the Closing, the Buyer shall or would receive shares of Common Stock in
payment of interest or principal under Note, upon exercise of the Warrant, so that the Buyer would, together with other shares
of Common Stock held by it or its Affiliates, own or beneficially own by virtue of such action or receipt of additional shares
of Common Stock a number of shares exceeding 9.99% of the number of shares of Common Stock outstanding on such date (the “Maximum
Percentage”), the Company shall not be obligated and shall not issue to the Buyer shares of Common Stock which would
exceed the Maximum Percentage, but only until such time as the Maximum Percentage would no longer be exceeded by any such receipt
of shares of Common Stock by the Buyer. The foregoing limitations are enforceable, unconditional and non-waivable and shall apply
to all Affiliates and assigns of the Buyer.

 

2.15          
No Shorting. For so long as Investor holds any securities of Company, neither Investor nor any of its Affiliates
will engage in or effect, directly or indirectly, any Short Sale of Common Stock.

 

2.16           Attorneys’
Fees and Cost of Collection. In the event of any action at law or in equity to enforce or interpret the terms of this
Agreement or any of the other Transaction Documents, the parties agree that the party who is awarded the most money shall be
deemed the prevailing party for all purposes and shall therefore be entitled to an additional award of the full amount of the
attorneys’ fees and expenses  paid by such prevailing party in connection with the litigation and/or dispute
without reduction or apportionment based upon the individual claims or defenses  giving rise to the fees and expenses.
Nothing herein shall restrict or impair a court’s power.

 

2.17          
Execution by Facsimile or PDF. This Agreement may be executed by facsimile or portable document format, which shall
have the same effect and force as an original signature.

 

 

[Remainder of page intentionally left
blank; signature page to follow]

 

 

 

 

    	 	4	 

     

    

 

SUBSCRIPTION AMOUNT:

 

	Original Principal Amount of Note:	$165,000.00
	Purchase Price:	$150,000.00

 

 

IN WITNESS WHEREOF,
the undersigned Buyer and the Company have caused this Agreement to be duly executed as of the date first above written.

 

 

THE COMPANY:

 

	
        Odyssey Group Intl, Inc.

         
	 
	By: /s/J. Michael Redmond	 
	
        Mr. Joseph Redmond

        Chief Executive Officer
	 
	
         

         
	 
	
         

        THE BUYER:

         

        LGH Investments, LLC

         
	 
	
        By: /s/Lucas Hoppel

        Mr. Lucas Hoppel

        Managing Member
	 

 

	 	 
	 	 

 

 

 

 

    	 	5	 

     

    

 

EXHIBIT A

 

NEITHER THIS NOTE NOR THE SECURITIES
INTO WHICH THIS NOTE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION
OF ANY STATE. THESE SECURITIES HAVE BEEN SOLD IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933,
AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO,
THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.

 

Odyssey Group Intl, Inc.

Convertible
Promissory Note

 

	Issuance Date;  December 11, 2020	Original Principal Amount:$165,000
	Note No. ODYY-1	Consideration Paid at Close:   $150,000
	 	 

 

FOR VALUE RECEIVED,
Odyssey Group Intl, Inc., a Nevada corporation with a par value of $0.001 per common share (“Par Value”) (the "Company"),
hereby promises to pay to the order of LGH Investments, LLC, a Wyoming limited liability company or registered assigns (the "Holder")
the amount set out above as the Original Principal Amount (as reduced pursuant to the terms hereof pursuant to redemption, conversion
or otherwise, the "Principal") when due, whether upon the Maturity Date (as defined below), acceleration, redemption
or otherwise (in each case in accordance with the terms hereof) and to pay interest ("Interest") on any outstanding
Principal at the applicable Interest Rate from the date set out above as the Issuance Date (the "Issuance Date")
until the same becomes due and payable, upon the Maturity Date or acceleration, conversion, redemption or otherwise (in each case
in accordance with the terms hereof).

 

The Original Principal
Amount is $165,000 (one hundred sixty-five thousand) plus accrued and unpaid interest and any other fees. The Consideration is
$150,000 (one hundred fifty thousand) payable by wire transfer (there exists a $15,000 original issue discount (the “OID”)).
The Holder shall pay $150,000 of Consideration upon closing of this Note.

 

(1)              
GENERAL TERMS

 

(a)              
Payment of Principal. The "Maturity Date" shall be nine months from
the date of closing, as may be extended at the option of the Holder in the event that, and for so long as, an Event of Default
(as defined below) shall not have occurred and be continuing on the Maturity Date (as may be extended pursuant to this Section
1) or any event shall not have occurred and be continuing on the Maturity Date (as may be extended pursuant to this Section 1)
that with the passage of time and the failure to cure would result in an Event of Default. 

 

(b)              
Interest. A one-time interest charge of eight percent (8%) (“Interest Rate”)
shall be applied on the Issuance Date to the Original Principal Amount. Interest hereunder shall be paid on the Maturity Date (or
sooner as provided herein) to the Holder or its assignee in whose name this Note is registered on the records of the Company regarding
registration and transfers of Notes in cash or converted into Common Stock at the Conversion Price provided the Equity Conditions
are satisfied.

 

(c)              
Security. This Note shall not be secured by any collateral or any assets pledged to
the Holder

 

 

 

    	 	6	 

     

    

 

(2)              
EVENTS OF DEFAULT.

 

(a)              
An “Event of Default”, wherever used herein, means any one of the following
events (whatever the reason and whether it shall be voluntary or involuntary or effected by operation of law or pursuant to any
judgment, decree or order of any court, or any order, rule or regulation of any administrative or governmental body):

 

(i)            The Company's failure to pay to the Holder any amount of Principal, Interest, or other amounts
when and as due under this Note (including, without limitation, the Company's failure to pay any redemption payments or amounts
hereunder); 

 

(ii)           A Conversion Failure as defined in section 3(b)(ii)

 

(iii)          The Company or any subsidiary of the Company shall commence, or there shall be commenced against
the Company or any subsidiary of the Company under any applicable bankruptcy or insolvency laws as now or hereafter in effect or
any successor thereto, or the Company or any subsidiary of the Company commences any other proceeding under any reorganization,
arrangement, adjustment of debt, relief of debtors, dissolution, insolvency or liquidation or similar law of any jurisdiction whether
now or hereafter in effect relating to the Company or any subsidiary of the Company or there is commenced against the Company or
any subsidiary of the Company any such bankruptcy, insolvency or other proceeding which remains undismissed for a period of 61
days; or the Company or any subsidiary of the Company is adjudicated insolvent or bankrupt; or any order of relief or other order
approving any such case or proceeding is entered; or the Company or any subsidiary of the Company suffers any appointment of any
custodian, private or court appointed receiver or the like for it or any substantial part of its property which continues undischarged
or unstayed for a period of sixty one (61) days; or the Company or any subsidiary of the Company makes a general assignment for
the benefit of creditors; or the Company or any subsidiary of the Company shall fail to pay, or shall state that it is unable to
pay, or shall be unable to pay, its debts generally as they become due; or the Company or any subsidiary of the Company shall call
a meeting of its creditors with a view to arranging a composition, adjustment or restructuring of its debts; or the Company or
any subsidiary of the Company shall by any act or failure to act expressly indicate its consent to, approval of or acquiescence
in any of the foregoing; or any corporate or other action is taken by the Company or any subsidiary of the Company for the purpose
of effecting any of the foregoing;

 

(iv)          The
Common Stock is suspended or delisted for trading on the Over the Counter OTCQB Venture Marketplace or OTC Pink Open Marketplace
(the “Primary Market”), unless due to an up-listing to a higher OTC exchange or a listed exchange. 

 

(v)           The Company loses its status as “DTC Eligible.”

 

(vi)          The Company shall become late or delinquent in its filing requirements as a fully-reporting
issuer registered with the Securities & Exchange Commission.

 

(vii)         The
Company shall fail to reserve and keep available out of its authorized Common Stock a number of shares equal to at least 2 (two)
times the full number of shares of Common Stock issuable upon conversion of all outstanding amounts under this Note.

 

(b)              
Upon the occurrence of any Event of Default that has not been cured within five calendar days
from the date of the Event of Default (a “Cure Failure”), the Outstanding Balance shall immediately increase to 135%
of the Outstanding Balance immediately prior to the occurrence of the Event of Default (the “Default Effect”) and a
daily penalty of $100 (one hundred) will accrue until the default is remedied. The Default Effect shall automatically apply upon
the occurrence of an Event of Default without the need for any party to give any notice or take any other action. Upon the occurrence
of any Event of Default, the Note shall become immediately due and payable and the Borrower shall pay to the Holder, in full satisfaction
of its obligations hereunder, an amount equal to the Outstanding Balance, all without demand, presentment or notice, all of which
hereby are expressly waived, together with all costs, including, without limitation, legal fees and expenses, of collection, and
the Holder shall be entitled to exercise all other rights and remedies available at law or in equity. 

 

 

 

 

 

    	 	7	 

     

    

 

(3)              
CONVERSION OF NOTE.The Holder shall have the right, but not the obligation,
to convert the Outstanding Balance into shares of the Company's Common Stock, on the terms and conditions set forth in this Section
3.

 

(a)              
Conversion Right. Subject to the provisions of Section 3(c), at any time or times,
the Holder shall be entitled to convert any portion of the outstanding and unpaid Conversion Amount (as defined below) into fully
paid and nonassessable shares of Common Stock in accordance with Section 3(b), at the Conversion Price (as defined below). The
number of shares of Common Stock issuable upon conversion of any Conversion Amount pursuant to this Section 3(a) shall be equal
to the quotient of dividing the Conversion Amount by the Conversion Price. The Company shall not issue any fraction of a share
of Common Stock upon any conversion. If the issuance would result in the issuance of a fraction of a share of Common Stock, the
Company shall round such fraction of a share of Common Stock up to the nearest whole share. The Company shall pay any and all transfer
agent fees, legal fees, costs and any other fees or costs that may be incurred or charged in connection with the issuance of shares
of the Company’s Common Stock to the Holder arising out of or relating to the conversion of this Note.

 

(i)            "Conversion Amount" means the portion of the Original Principal Amount and
Interest to be converted, plus any penalties, redeemed or otherwise with respect to which this determination is being made.

 

(ii)           "Conversion Price" shall equal $0.15 (fifteen) cents, subject to adjustment
as provided in this Note. If an Event of Default occurs, the Conversion Price shall be the lesser of (a). $0.15 (fifteen) cents
or (b). 70% of the lowest traded price in the prior twenty trading days immediately preceding the Notice of Conversion.

 

(b)              
Mechanics of Conversion.

 

(i)            Optional
Conversion. To convert any Conversion Amount into shares of Common Stock on any date (a "Conversion Date"),
the Holder shall (A) transmit by email, facsimile (or otherwise deliver), for receipt on or prior to 11:59 p.m., New York, NY
Time, on such date, a copy of an executed notice of conversion in the form attached hereto as Exhibit A (the "Conversion
Notice") to the Company. On or before the third Business Day following the date of receipt of a Conversion Notice (the
"Share Delivery Date"), the Company shall (A) if legends are not required to be placed on certificates of Common
Stock pursuant to the then existing provisions of Rule 144 of the Securities Act of 1933 (“Rule 144”) and provided
that the Transfer Agent is participating in the Depository Trust Company's ("DTC") Fast Automated Securities
Transfer Program, credit such aggregate number of shares of Common Stock to which the Holder shall be entitled to the Holder's
or its designee's balance account with DTC through its Deposit Withdrawal Agent Commission system or (B) if the Transfer Agent
is not participating in the DTC Fast Automated Securities Transfer Program, issue and deliver to the address as specified in the
Conversion Notice, a certificate, registered in the name of the Holder or its designee, for the number of shares of Common Stock
to which the Holder shall be entitled which certificates shall not bear any restrictive legends unless required pursuant the Rule
144. If this Note is physically surrendered for conversion and the outstanding Principal of this Note is greater than the Principal
portion of the Conversion Amount being converted, then the Company shall, upon request of the Holder, as soon as practicable and
in no event later than three (3) Business Days after receipt of this Note and at its own expense, issue and deliver to the holder
a new Note representing the outstanding Principal not converted. The Person or Persons entitled to receive the shares of Common
Stock issuable upon a conversion of this Note shall be treated for all purposes as the record holder or holders of such shares
of Common Stock upon the transmission of a Conversion Notice.

 

(ii)           Company's Failure to Timely Convert. If within two (2) Trading Days after the Company's
receipt of the facsimile or email copy of a Conversion Notice the Company shall fail to issue and deliver to Holder via “DWAC/FAST”
electronic transfer the number of shares of Common Stock to which the Holder is entitled upon such holder's conversion of any Conversion
Amount (a "Conversion Failure"), the Original Principal Amount of the Note shall increase by $1,000 per day until
the Company issues and delivers a certificate to the Holder or credit the Holder's balance account with DTC for the number of shares
of Common Stock to which the Holder is entitled upon such holder's conversion of any Conversion Amount (under Holder’s and
Company’s expectation that any damages will tack back to the Issuance Date). Company will not be subject to any penalties
once its transfer agent processes the shares to the DWAC system. If the Company fails to deliver shares in accordance with
the timeframe stated in this Section, resulting in a Conversion Failure, the Holder, at any time prior to selling all of those
shares, may rescind any portion, in whole or in part, of that particular conversion attributable to the unsold shares and have
the rescinded conversion amount returned to the Outstanding Balance with the rescinded conversion shares returned to the Company
(under Holder’s and Company’s expectations that any returned conversion amounts will tack back to the original date
of the Note).

 

 

 

 

 

    	 	8	 

     

    

 

(iii)          DTC Eligibility & Sub-Penny. If the Company fails to maintain its status as “DTC
Eligible” for any reason, or, if the effective Conversion Price as calculated in Section 3(a)(ii) is less than $0.01 at any
time (regardless of whether or not a Conversion Notice has been submitted to the Company), the Principal Amount of the Note shall
increase by ten thousand dollars ($10,000) (under Holder’s and Company’s expectation that any Principal Amount increase
will tack back to the Issuance Date). In addition, the Conversion Price shall be permanently redefined to equal the lesser of (a)
$0.01 or (b) 50% of the lowest trade occurring during the twenty (20) consecutive Trading Days immediately preceding the applicable
Conversion Date on which the Holder elects to convert all or part of this Note, subject to adjustment as provided in this Note.

 

(iv)          Book-Entry. Notwithstanding anything to the contrary set forth herein, upon conversion
of any portion of this Note in accordance with the terms hereof, the Holder shall not be required to physically surrender this
Note to the Company unless (A) the full Conversion Amount represented by this Note is being converted or (B) the Holder has provided
the Company with prior written notice (which notice may be included in a Conversion Notice) requesting reissuance of this Note
upon physical surrender of this Note. The Holder and the Company shall maintain records showing the Principal and Interest converted
and the dates of such conversions or shall use such other method, reasonably satisfactory to the Holder and the Company, so as
not to require physical surrender of this Note upon conversion.

 

(c)         
Limitations on Conversions or Trading.

 

(i)            Beneficial Ownership. The Company shall not effect any conversions of this Note and
the Holder shall not have the right to convert any portion of this Note or receive shares of Common Stock as payment of interest
hereunder to the extent that after giving effect to such conversion or receipt of such interest payment, the Holder, together with
any affiliate thereof, would beneficially own (as determined in accordance with Section 13(d) of the Exchange Act and the rules
promulgated thereunder) in excess of 4.99% of the number of shares of Common Stock outstanding immediately after giving effect
to such conversion or receipt of shares as payment of interest. Since the Holder will not be obligated to report to the Company
the number of shares of Common Stock it may hold at the time of a conversion hereunder, unless the conversion at issue would result
in the issuance of shares of Common Stock in excess of 4.99% of the then outstanding shares of Common Stock without regard to any
other shares which may be beneficially owned by the Holder or an affiliate thereof, the Holder shall have the authority and obligation
to determine whether the restriction contained in this Section will limit any particular conversion hereunder and to the extent
that the Holder determines that the limitation contained in this Section applies, the determination of which portion of the principal
amount of this Note is convertible shall be the responsibility and obligation of the Holder. If the Holder has delivered a Conversion
Notice for a principal amount of this Note that, without regard to any other shares that the Holder or its affiliates may beneficially
own, would result in the issuance in excess of the permitted amount hereunder, the Company shall notify the Holder of this fact
and shall honor the conversion for the maximum principal amount permitted to be converted on such Conversion Date in accordance
with Section 3(a) and, any principal amount tendered for conversion in excess of the permitted amount hereunder shall remain outstanding
under this Note. In the event that the Market Capitalization of the Company falls below $2,500,000, the term “4.99%”
above shall be permanently replaced with “9.99%”. “Market Capitalization” shall be defined as the product
of (a) the closing price of the Common Stock of the Common stock multiplied by (b) the number of shares of Common Stock outstanding
as reported on the Company’s most recently filed Form 10-K or Form 10-Q. The provisions of this Section may be waived by
Holder upon not less than 65 days prior written notification to the Company.

 

(ii)           Capitalization. So long as this as this Note is outstanding, upon written request of
the Holder, the Company shall furnish to the Holder the then-current number of common shares issued and outstanding, the then-current
number of common shares authorized, and the then-current number of shares reserved for third parties.

 

(d)         
Other Provisions.

 

(i)            Share Reservation.The Company shall at all times reserve and keep available out
of its authorized Common Stock a number of shares equal to at least 3 (three) times the full number of shares of Common Stock issuable
upon conversion of all outstanding amounts under this Note; and within 3 (three) Business Days following the receipt by the Company
of a Holder's notice that such minimum number of shares of Common Stock is not so reserved, the Company shall promptly reserve
a sufficient number of shares of Common Stock to comply with such requirement. The Company will at all times reserve at least 2,000,000
shares of Common Stock for conversion.

 

(ii)           Prepayment.The Company may prepay this Note at anytime without penalty.

 

(iii)          All calculations under this Section 3 shall be rounded up to the nearest $0.00001 or whole
share.

 

 

 

 

    	 	9	 

     

    

 

(iv)          Nothing herein shall limit a Holder's right to pursue actual damages or declare an Event of
Default pursuant to Section 2 herein for the Company's failure to deliver certificates representing shares of Common Stock upon
conversion within the period specified herein and such Holder shall have the right to pursue all remedies available to it at law
or in equity including, without limitation, a decree of specific performance and/or injunctive relief, in each case without the
need to post a bond or provide other security. The exercise of any such rights shall not prohibit the Holder from seeking to enforce
damages pursuant to any other Section hereof or under applicable law. 

 

(4)              
PIGGYBACK REGISTRATION RIGHTS. The Company shall include on the current registration
statement the Company has with SEC (or on the subsequent registration statement if such registration statement is withdrawn) all
shares issuable upon conversion of this Note. Failure to do so will result in liquidated damages of 15% of the outstanding principal
balance of this Note, but not less than $15,000, being immediately due and payable to the Holder at its election in the form of
cash payment or addition to the balance of this Note.

 

(5)              
Terms of Future Financings. So long as this Note is outstanding, upon any issuance
by the Company or any of its subsidiaries of any security with any term more favorable to the holder of such security or with a
term in favor of the holder of such security that was not similarly provided to the Holder in this Note, then the Company shall
notify the Holder of such additional or more favorable term and such term, at Holder’s option, shall become a part of the
transaction documents with the Holder. The types of terms contained in another security that may be more favorable to the holder
of such security include, but are not limited to, terms addressing conversion discounts, conversion lookback periods, interest
rates, original issue discounts, stock sale price, private placement price per share, and warrant coverage. Financings in which
the Company receives proceeds of one million dollars or greater or excluded from the Terms of Future Financings.

 

 

(6)              
REISSUANCE OF THIS NOTE.

(a)              
Assignability. The Company may not assign this Note. This Note will be binding upon
the Company and its successors and will inure to the benefit of the Holder and its successors and assigns and may be assigned by
the Holder to anyone of its choosing without Company’s approval. 

 

(b)              
Lost, Stolen or Mutilated Note. Upon receipt by the Company of evidence reasonably
satisfactory to the Company of the loss, theft, destruction or mutilation of this Note, and, in the case of loss, theft or destruction,
of any indemnification undertaking by the Holder to the Company in customary form and, in the case of mutilation, upon surrender
and cancellation of this Note, the Company shall execute and deliver to the Holder a new Note representing the outstanding Principal.

 

(7)              
NOTICES.Any notices, consents, waivers or other communications required or permitted
to be given under the terms hereof must be in writing and will be deemed to have been delivered: (i) upon receipt, when delivered
personally; (ii) upon receipt, when sent by facsimile (provided confirmation of transmission is mechanically or electronically
generated and kept on file by the sending party) (iii) upon receipt, when sent by email; or (iv) one (1) Trading Day after deposit
with a nationally recognized overnight delivery service, in each case properly addressed to the party to receive the same. The
addresses and facsimile numbers for such communications shall be those set forth in the communications and documents that each
party has provided the other immediately preceding the issuance of this Note or at such other address and/or facsimile number and/or
to the attention of such other person as the recipient party has specified by written notice given to each other party three (3)
Business Days prior to the effectiveness of such change. Written confirmation of receipt (i) given by the recipient of such notice,
consent, waiver or other communication, (ii) mechanically or electronically generated by the sender's facsimile machine containing
the time, date, recipient facsimile number and an image of the first page of such transmission or (iii) provided by a nationally
recognized overnight delivery service, shall be rebuttable evidence of personal service, receipt by facsimile or receipt from a
nationally recognized overnight delivery service in accordance with clause (i), (ii) or (iii) above, respectively.

 

The addresses for such communications shall
be:

 

If to the Company, to:

 

Odyssey Group Intl, Inc.

ATT: Joseph Redmond, CEO

2372 Morse Ave

Irvine, CA 92614

Email: michael@odysseygi.com

 

 

 

 

 

    	 	10	 

     

    

 

With Copy to which shall not constitute notice:

 

Joshua D. Brinen, Esq.

Brinen & Associates, LLC

90 Broad Street, Tenth Floor

New York, New York 10004

 

Telephone (212) 330-8151

Facsimile (212) 227-0201

 

jbrinen@brinenlaw.com

 

If to the Holder:

 

Lucas Hoppel

Phone: 858-232-5110

Email: Luke@LGHInvestments.com

(8)              
APPLICABLE LAW AND VENUE. This Note shall be governed by and construed in accordance
with the laws of the State of California, without giving effect to conflicts of laws thereof. Any action brought by either party
against the other concerning the transactions contemplated by this Agreement shall be brought only in the state courts of California
or in the federal courts located in the city of San Diego, in the State of California. Both parties and the individuals signing
this Agreement agree to submit to the jurisdiction of such courts.

 

(9)              
WAIVER. Any waiver by the Holder of a breach of any provision of this Note shall not
operate as or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this
Note. The failure of the Holder to insist upon strict adherence to any term of this Note on one or more occasions shall not be
considered a waiver or deprive that party of the right thereafter to insist upon strict adherence to that term or any other term
of this Note. Any waiver must be in writing.

 

(10)          
   LIQUIDATED DAMAGES. Holder and Company agree that in the event Company fails to comply
with any of the terms or provisions of this Note, Holder's damages would be uncertain and difficult (if not impossible) to accurately
estimate because of the parties' inability to predict future interest rates, future share prices, future trading volumes and other
relevant factors. Accordingly, Holder and Company agree that any fees, balance adjustments, default interest or other charges assessed
under this Note are not penalties but instead are intended by the parties to be, and shall be deemed, liquidated damages (under
Holder's and Company's expectations that any such liquidated damages will tack back to the Closing Date for purposes of determining
the holding period under Rule 144).

 

(11)          
   Counterparts. This Agreement may be executed in several counterparts and all so executed shall
constitute one Agreement, binding on all the parties hereto even though all the parties are not signatories to the original or
the same counterpart. 

 

(12)          
   Execution by Facsimile or PDF. This Agreement may be executed by facsimile or portable document
format, which shall have the same effect and force as an original signature. 

 

[Signature Page Follows]

 

 

 

 

    	 	11	 

     

    

 

 

IN WITNESS WHEREOF,
the Company has caused this Convertible Note to be duly executed by a duly authorized officer as of the date set forth above.

 

 

	 	COMPANY:
	 	 
	 	Odyssey Group Intl, Inc.
	 	 
	 	By: /s/ J. Michael Redmond                
	 	 
	 	Name: Joseph Redmond
	 	 
	 	Title: Chief Executive Officer
	 	 
	 	 
	 	HOLDER:
	 	 
	 	LGH Investments, LLC
	 	 
	 	By: /s/ Lucas 
	 	 
	 	 
	 	 
	 	 

 

 

 

 

 

 

 

 

[Signature Page to Note No. ODYY-1]

 

 

 

 

    	 	12	 

     

    

 

EXHIBIT A

 

CONVERSION NOTICE

 

[Company Contact, Position]

[Company Name]

[Company Address]

[Contact Email Address}

 

The undersigned hereby elects to convert a portion of the $________ Convertible Note _______ issued to Lucas Hoppel on ____________ into Shares of Common Stock of ____________ according to the conditions set forth in such Note as of the date written below.

 

 

By accepting this notice of conversion, you are acknowledging that the number of shares to be delivered represents less than 10% (ten percent) of the common stock outstanding.  If the number of shares to be delivered represents more than 9.99% of the common stock outstanding, this conversion notice shall immediately automatically extinguish and debenture Holder must be immediately notified.

 

	Date of Conversion:	_________________________
	 	 
	Conversion Amount:	_________________________
	 	 
	Conversion Price:	_________________________
	 	 
	Shares to be Delivered:	_________________________

 

Shares delivered in name of:

 

LGH Investments, LLC

 

Signature:                                                       ____________________________

 

 

 

 

 

 

    	 	13	 

     

    

 

EXHIBIT B

 

 

THIS WARRANT AND THE
SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT
AND THE SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE
OF AN EFFECTIVE REGISTRATION STATEMENT OR APPLICABLE EXEMPTION OR SAFE HARBOR PROVISION.

 

 

COMMON STOCK PURCHASE WARRANT

 

Odyssey
Group intl, Inc.

 

	Warrant Shares: 470,000	Initial Issue Date: December 11,
2020

  

THIS COMMON STOCK PURCHASE
WARRANT (the “Warrant”) certifies that, for value received, LGH Investments, LLC, a Wyoming limited liability
company, or its assigns (the “Investor” or the “Holder”) is entitled, upon the terms and
subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Initial Issue Date
(the “Initial Exercise Date”) and on or prior to the close of business on the five (5) year anniversary of the
Initial Exercise Date (as subject to adjustment hereunder, the “Termination Date”), to subscribe for and purchase
from Odyssey Group Intl, Inc., a Nevada corporation (the “Issuer” or the “Company”), up to
470,000 shares (as subject to adjustment herein, the “Warrant Shares”) of common stock, par value of $0.001,
of the Company (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall
be equal to the Exercise Price, as defined in Section 1.2.

 

ARTICLE 1 EXERCISE RIGHTS

 

The Holder will have
the right to exercise this Warrant to purchase shares of Common Stock as set forth below. Capitalized terms used and not otherwise
defined herein shall have the meanings set forth in that certain Securities Purchase Agreement, dated December 11, 2020 between
the Company and the Holder (the “Purchase Agreement”).

 

1.1       Exercise
of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, from and after the
Initial Exercise Date, and then at any time, by delivery to the Company (or such other office or agency of the Company as it may
designate by notice in writing to the registered Holder at the address of the Holder appearing on the books of the Company) of
a duly executed facsimile or emailed copy of the Notice of Exercise form annexed hereto. Within three (3) Business Days following
the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified in the applicable
Notice of Exercise by wire transfer or check drawn on a United States bank unless the cashless exercise procedure specified in
Section 1.3 below is specified in the applicable Notice of Exercise. Partial exercises of this Warrant resulting in purchases of
a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of
Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the
Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall
deliver any objection to any Notice of Exercise form within seventy-two (72) hours of receipt of such notice. The Holder and any
assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the
purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given
time may be less than the amount stated on the face hereof. “Business Day” shall mean any day on which the banks are
open for business in New York, New York.

 

 

 

 

    	 	14	 

     

    

 

1.2       Exercise
Price. The exercise price per share of Common Stock under this Warrant shall be $0.35 per share, subject to adjustment hereunder
(the “Exercise Price”).

 

1.3       Cashless
Exercise. If at any time after the earlier of (i) the six (6) month anniversary of the date of the Agreement and (ii) the completion
of the then-applicable holding period required by Rule 144, or any successor provision then in effect, there is no effective Registration
Statement registering, or no current prospectus available for, the resale of the Warrant Shares by the Holder, then this Warrant
may also be exercised, in whole or in part, at such time by means of a “cashless exercise” in which the Holder shall
be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

(A) = the
highest traded Price in the ten trading days immediately preceding the date on which Holder elects to exercise this Warrant by
means of a “cashless exercise,” as set forth in the applicable Notice of Exercise;

 

(B) = the
Exercise Price of this Warrant, as adjusted hereunder; and

 

(X) = the
number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
exercise were by means of a cash exercise rather than a cashless exercise.

 

1.4       Delivery
of Warrant Shares. Warrant Shares purchased hereunder will be delivered to Holder by 2:30 pm EST within five (5) Business Days
of Notice of Exercise by “DWAC/FAST” electronic transfer (such date, the “Warrant Share Delivery Date”).
For example, if Holder delivers a Notice of Exercise to the Company at 5:15 pm eastern time on Monday January 1st, the
Company’s transfer agent must deliver shares to Holder’s broker via “DWAC/FAST” electronic transfer by
no later than 2:30 pm eastern time on Monday, January 8th. The Warrant Shares shall be deemed to have been issued, and Holder or
any other person so designated to be named therein shall be deemed to have become a holder of record of such shares for all purposes,
as of the date of delivery of the Notice of Exercise. Holder may assess penalties or liquidated damages (both referred to herein
as “penalties”) as follows. For each exercise, in the event that shares are not delivered by the fifth Business Day
(inclusive of the day of exercise), the Company shall pay the Holder in cash a penalty of $500 per day for each day after the fifth
Business Day (inclusive of the day of exercise) until share delivery is made. The Company will not be subject to any penalties
once its transfer agent correctly processes the shares to the DWAC system.

 

1.5       Delivery
of Warrant. The Holder shall not be required to physically surrender this Warrant to the Company. If the Holder has purchased
all of the Warrant Shares available hereunder and the Warrant has been exercised in full, this Warrant shall automatically be cancelled
without the need to surrender the Warrant to the Company for cancellation. If this Warrant shall have been exercised in part, the
Company shall, at the request of Holder and upon surrender of this Warrant, at the time of delivery of the Warrant Shares, deliver
to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant,
which new Warrant shall in all other respects be identical with this Warrant and, for purposes of Rule 144, shall tack back to
the original date of this Warrant.

 

1.6       Warrant
Exercise Rescission Rights. If the Warrant Shares are not delivered by DWAC/FAST electronic transfer or in accordance with
the timeframe stated in Section 1.5, Holder may, at any time prior to selling those Warrant Shares rescind such exercise, in whole
or in part, in which case the Company must, within three (3) days of receipt of notice from the Holder, repay to the Holder the
portion of the exercise price so rescinded and reinstate the portion of the Warrant and equivalent number of Warrant Shares for
which the exercise was rescinded and, for purposes of Rule 144, such reinstated portion of the Warrant and the Warrant Shares shall
tack back to the original date of this Warrant. If Warrant Shares were issued to Holder prior to Holder’s rescission notice,
upon return of payment from the Company, Holder will, within three (3) days of receipt of payment, commence procedures to return
the Warrant Shares to the Company.

 

1.7       Charges,
Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or
other incidental expense in respect of the issuance of such shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder. The
Company shall pay all transfer agent fees required for same-day processing of any Notice of Exercise.

 

1.8       Holder’s
Exercise Limitations. Unless otherwise agreed in writing by both the Company and the Holder, at no time will the Holder exercise
any amount of this Warrant to purchase Common Stock that would result in the Holder owning more than 4.99% of the Common Stock
outstanding of the Company (the “Beneficial Ownership Limitation”). Upon the written or oral request of Holder,
the Company shall within twenty-four (24) hours confirm orally and in writing to the Holder the number of shares of Common Stock
then outstanding.

 

 

 

    	 	15	 

     

    

 

1.10       Physical
Delivery of Warrant Shares. In the event that the Warrant Shares are required by securities laws to contain a restrictive legend,
then the Holder shall be delivered a physical certificate representing the Warrant Shares within ten (10) business days, notwithstanding
anything contained herein in Sections 1.4, 1.5 and 1.6, which sections shall be deemed inapplicable to the Warrant exercise being
completed by the Holder.

 

ARTICLE 2 ADJUSTMENTS

 

2.1       Stock
Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable
in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon
exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including
by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification
(or issues by reorganization) of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise
Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury
shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common
Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately
adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section
2.1 shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend
or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or reclassification
(or reorganization).

 

2.2       Subsequent
Equity Sales. If the Company at any time while this Warrant is outstanding, shall sell or grant any option to purchase, or
sell or grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any option to purchase
or other disposition) any Common Stock (including pursuant to the terms of any outstanding securities issued prior to the issuance
of this security (including, but not limited to, warrants, convertible notes, or other agreements)) or any security entitling the
holder thereof (including sales or grants to the Holder) to acquire Common Stock, including, without limitation, any debt, preferred
stock, right, option, warrant or other instrument that is convertible into or exercisable or exchangeable for, or otherwise entitles
the holder thereof to receive, Common Stock (a “Common Stock Equivalent”), at an effective price per share less
than the Exercise Price then in effect (such lower price, the “Base Share Price” and such issuances collectively,
a “Dilutive Issuance”) (it being understood and agreed that if the holder of the Common Stock or Common Stock
Equivalents so issued shall at any time, whether by operation of purchase price adjustments, reset provisions, floating conversion,
exercise or exchange prices or otherwise, or due to warrants, options or rights per share which are issued in connection with such
issuance, be entitled to receive shares of Common Stock at an effective price per share that is less than the Exercise Price, such
issuance shall be deemed to have occurred for less than the Exercise Price on such date of the Dilutive Issuance at such effective
price regardless of whether such holder has received or ever receives shares at such effective price), then simultaneously with
the consummation of each Dilutive Issuance the Exercise Price shall be reduced and only reduced to equal the Base Share Price and
consequently the number of Warrant Shares issuable hereunder shall be increased such that the Aggregate Exercise Amount hereunder,
after taking into account the decrease in the Exercise Price, shall be equal to the Aggregate Exercise Amount prior to such adjustment.
Such adjustment shall be made whenever such Common Stock or Common Stock Equivalents are issued. The Company shall notify the Holder,
in writing, no later than the business day following the issuance or deemed issuance of any Common Stock or Common Stock Equivalents
subject to this Section 2.2, indicating therein the applicable issuance price, or applicable reset price, exchange price, conversion
price and other pricing terms (such notice, the “Dilutive Issuance Notice”). In addition, the Company and/or
its transfer agent shall provide the Holder, whenever the Holder requests at any time while this Warrant is outstanding, a schedule
of all issuances of Common Stock or Common Stock Equivalents since the date of the Agreement, including the applicable issuance
price, or applicable reset price, exchange price, conversion price, exercise price and other pricing terms. The term issuances
shall also include all agreements to issue, or prospectively issue Common Stock or Common Stock Equivalents, regardless of whether
the issuance contemplated by such agreement is consummated. The Company shall notify the Holder in writing of any issuances within
twenty-four (24) hours of such issuance. For purposes of clarification, whether or not the Company provides a Dilutive Issuance
Notice pursuant to this Section 2.2, upon the occurrence of any Dilutive Issuance, the Holder is entitled to receive a number of
Warrant Shares based upon the Base Share Price regardless of whether the Holder accurately refers to the Base Share Price in the
Notice of Exercise. If the Company enters into a Variable Rate Transaction, the Company shall be deemed to have issued Common Stock
or Common Stock Equivalents at the lowest possible conversion or exercise price at which such securities may be converted or exercised.
“Variable Rate Transaction” means a transaction in which the Company (i) issues or sells any debt or equity
securities that are convertible into, exchangeable or exercisable for, or include the right to receive, additional shares of Common
Stock either (A) at a conversion price, exercise price or exchange rate or other price that is based upon, and/or varies with,
the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance of such debt or equity
securities or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date after the initial
issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly related
to the business of the Company or the market for the Common Stock or (ii) enters into any agreement, including, but not limited
to, an equity line of credit, whereby the Company may sell securities at a future determined price.

 

 

 

 

    	 	16	 

     

    

 

2.3       Pro
Rata Distributions. If the Company, at any time while this Warrant is outstanding, shall distribute to all holders of Common
Stock (and not to the Holder) evidences of its indebtedness or assets (including cash and cash dividends) or rights or warrants
to subscribe for or purchase any security other than the Common Stock, then in each such case the Exercise Price shall be adjusted
by multiplying the Exercise Price in effect immediately prior to the record date fixed for determination of stockholders entitled
to receive such distribution by a fraction of which the denominator shall be the VWAP determined as of the record date mentioned
above, and of which the numerator shall be such VWAP on such record date less the then per share fair market value at such record
date of the portion of such assets or evidence of indebtedness or rights or warrants so distributed applicable to one outstanding
share of the Common Stock as determined by the Board of Directors in good faith. In either case the adjustments shall be described
in a statement provided to the Holder of the portion of assets or evidences of indebtedness so distributed or such subscription
rights applicable to one share of Common Stock. Such adjustment shall be made whenever any such distribution is made and shall
become effective immediately after the record date mentioned above.

 

2.4       Notice
to Holder. Whenever the Exercise Price is adjusted pursuant to any provision of this Article 2, the Company shall promptly
notify the Holder (by written notice) setting forth the Exercise Price after such adjustment and any resulting adjustment to the
number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

 

ARTICLE 3 COMPANY COVENANTS

 

3.1       No
Adverse Actions. Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including,
without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance
of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the
taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against
impairment. Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares
above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action
as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and non-assessable Warrant
Shares upon the exercise of this Warrant, and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions
or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform
its obligations under this Warrant.

 

ARTICLE 4 MISCELLANEOUS

 

4.1       Representation
by the Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any
exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for
distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.

 

4.2       Transferability.
Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder (including, without limitation,
any registration rights) are transferable, in whole or in part, by a written assignment of this Warrant duly executed by the Holder
or its agent or attorney. If necessary to obtain a new warrant for any assignee, the Company, upon surrender of this Warrant, shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination
or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion
of this Warrant not so assigned, and such new Warrants, for purposes of Rule 144, shall tack back to the original date of this
Warrant. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant
Shares without having a new Warrant issued.

 

4.3       Assignability.
The Company may not assign this Warrant without prior written consent of the Holder. This Warrant will be binding upon the Company
and its successors, and will inure to the benefit of the Holder and its successors and assigns, and may be assigned by the Holder
to anyone of its choosing without the Company’s approval.

 

 

 

 

    	 	17	 

     

    

 

4.4       Notices.
Any notice required or permitted hereunder must be in writing and either personally served, sent by facsimile or email transmission,
or sent by overnight courier. Notices will be deemed effectively delivered at the time of transmission if by facsimile or email,
and if by overnight courier the Business Day after such notice is deposited with the courier service for delivery.

 

4.5       Governing
Law, Legal Proceedings, and Arbitration. This Warrant will be governed by, construed
and enforced in accordance with the substantive laws of the State of California, without regard to the conflict of laws principles
thereof. 

 

Any
action brought by either party against the other arising out of or related to this Warrant, or any other agreements between the
parties, shall be commenced only in the state or federal courts of general jurisdiction located in the State of California, except
that all such disputes between the parties shall be subject to alternative dispute resolution through binding arbitration upon
agreement by parties. The Parties agree that, in connection with any such arbitration proceeding, each shall submit
or file any claim which would constitute a compulsory counterclaim within the same proceeding as the claim to which it relates.
Any such claim that is not submitted or filed in such proceeding shall be waived and such party will forever be barred from asserting
such a claim. The Parties agree to submit to the jurisdiction of such courts or to such arbitration panel, as the case may be.

 

If the Investor elects alternative dispute
resolution by arbitration, the arbitration proceedings shall be conducted in California and administered by the American Arbitration
Association in accordance with its Commercial Arbitration Rules and Mediation Procedures in effect on the Initial Issue Date of
this Warrant, except as modified by this Warrant. The American Arbitration Association must receive the demand in writing and signed
by both Parties for arbitration prior to the date when the institution of legal or equitable proceedings would be barred by the
applicable statute of limitations, unless legal or equitable proceedings between the parties have already commenced, and the receipt
by the American Arbitration Association of a written demand for arbitration also shall constitute the institution of legal or equitable
proceedings for statute of limitations purposes. The parties shall be entitled to limited discovery at the discretion of the arbitrator(s)
who may, but are not required to, allow depositions. The parties acknowledge that the arbitrators’ subpoena power is not
subject to geographic limitations. The arbitrator(s) shall have the right to award individual relief which he or she deems proper
under the evidence presented and applicable law and consistent with the parties’ rights to, and limitations on, damages and
other relief as expressly set forth in this Warrant. The award and decision of the arbitrator(s) shall be conclusive and binding
on the Parties, and judgment upon the award may be entered in any court of competent jurisdiction. The Investor reserves the right,
but shall have no obligation, to advance the Issuer’s share of the costs, fees and expenses of any arbitration proceeding,
including any arbitrator fees, in order for such arbitration proceeding to take place, and by doing so will not be deemed to have
waived or relinquished its right to seek the recovery of those amounts from the arbitrator, who shall provide for such relief in
the final award, in addition to the costs, fees, and expenses that are otherwise recoverable. The foregoing agreement to arbitrate
shall be specifically enforceable under applicable law in any court having jurisdiction thereof.

 

4.6       Delivery
of Process by Holder to the Company. In the event of any action or proceeding by Holder against the Company, and only by Holder
against the Company, service of copies of summons and/or complaint and/or any other process which may be served in any such action
or proceeding may be made by Holder via U.S. Mail, overnight delivery service such as FedEx or UPS, email, fax, or process server
upon mailing or delivering a copy of such process to the Company at its last known address as set forth in its most recent SEC
filing.

 

4.7       No
Rights as Stockholder Until Exercise. This Warrant does not entitle the Holder to any voting rights, dividends or other rights
as a stockholder of the Company prior to the exercise hereof as set forth in Section 1.1. So long as this Warrant is unexercised,
this Warrant carries no voting rights and does not convey to the Holder any “control” over the Company, as such term
may be interpreted by the SEC under the Securities Act or the Exchange Act, regardless of whether the price of the Company’s
Common Stock exceeds the Exercise Price.

 

4.8       Limitation
of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase
Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder
for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.

 

 

 

 

    	 	18	 

     

    

 

4.9       Attorney’s
Fees. In the event any attorney is employed by either party to this Warrant with regard to any legal or equitable action, arbitration
or other proceeding brought by such party for the enforcement of this Warrant or because of an alleged dispute, breach, default
or misrepresentation in connection with any of the provisions of this Warrant, the prevailing party in such proceeding will be
entitled to recover from the other party reasonable attorneys’ fees and other costs and expenses incurred, in addition to
any other relief to which the prevailing party may be entitled.

 

4.10     Opinion
of Counsel. In the event that an opinion of counsel is needed for any matter related to this Warrant, Holder has the right
to have any such opinion provided by its counsel.

 

4.11     Amendment;
Waivers. The term “Warrant” and all references thereto, as used throughout this instrument, means this instrument
as originally executed, or if later amended or supplemented, then as so amended or supplemented. No provision of this Warrant may
be waived, modified, supplemented or amended except in a written instrument signed, in the case of an amendment, by the Company
and the Holder, or in the case of a waiver, by the party against whom enforcement of any such waived provision is sought. No waiver
of any default with respect to any provision, condition or requirement of this Warrant shall be deemed to be a continuing waiver
in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall
any delay or omission of any part to exercise any right hereunder in any manner impair the exercise of any such right.

 

4.12     Nonwaiver.
No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of
such right or otherwise prejudice the Holder’s rights, powers or remedies.

 

4.13     No
Shorting. Holder agrees that so long as this Warrant remains unexercised in whole or in part, Holder will not enter into or
effect any “short sale” of the common stock or hedging transaction which establishes a net short position with respect
to the common stock of the Company. The Company acknowledges and agrees that as of the date of delivery to the Company of a fully
and accurately completed Notice of Exercise, Holder immediately owns the common shares described in the Notice of Exercise and
any sale of those shares issuable under such Notice of Exercise would not be considered short sales.

 

4.14     Counterparts.
This Agreement may be executed in several counterparts and all so executed shall constitute one Agreement, binding on all the parties
hereto even though all the parties are not signatories to the original or the same counterpart.

 

4.15     Execution
by Facsimile or PDF. This Agreement may be executed by facsimile or portable document format, which shall have the same effect
and force as an original signature.

 

[Remainder of page intentionally left
blank; signature page to follow]

 

 

 

 

 

 

    	 	19	 

     

    

 

 

IN WITNESS WHEREOF,
the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

 

COMPANY: Odyseey Group Intl, Inc.

 

 

 

By: /s/J. Michael Redmond

 

Name: Joseph Redmond

 

Title: Chief Executive Officer

 

 

 

 

HOLDER: LGH INVESTMENTS, LLC

 

 

By: /s/Lucas Hoppel

 

Name: Lucas Hoppel

 

Title: Managing Member

 

 

 

 

 

 

    	 	20	 

     

    

 

 

NOTICE OF EXERCISE

 

To:odyssey
group intl, iNC.

 

(1)  
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant
to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together
with all applicable transfer taxes, if any.

 

(2)  
Payment shall take the form of (check applicable box):

 

[_] in lawful
money of the United States; or

 

[_] the cancellation
of such number of Warrant Shares as is necessary, in accordance with the formula set forth in Section 1.3, to exercise this Warrant
with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in Section
1.3.

 

(3)  
Please issue a certificate or certificates representing said Warrant Shares in the name of
the undersigned or in such other name as is specified below:

_______________________________

 

 

The Warrant Shares shall be delivered to
the following DWAC Account Number:

 

_______________________________

 

_______________________________

 

_______________________________

 

(4) Accredited Investor.
The undersigned is an “accredited investor” as defined in Regulation D promulgated under the Securities Act of 1933,
as amended.

 

[SIGNATURE
OF HOLDER]

 

 

Name: _______________________________________

Date: ________________________________________

 

 

 

 

 

 

 

 

 

 

 

    	 	21

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}]]